An inhaled insulin being developed by MannKind Corp produces comparable improvements in blood sugar control to rapid-acting insulin analog (RAA) given by injection, researchers said on Saturday.

Data emerging on the safety and efficacy of the new oral antidiabetic agents were presented this week at the European Association for the Study of Diabetes 2006 Meeting.

Galvus dropped A1c by 1.8% without weight gain.

New data presented yesterday for the first time at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated a mean reduction in A1C of 2.1% from a mean baseline A1C of 8.8% and a reduction of 2.9% for those with a mean …

Levemir improves glucose control without weight gain and hypoglycemia.

Washington University researchers have developed a potential cure for Type 2 diabetes.

A new form of insulin which is inhaled rather than injected works even if patients have a respiratory infections or are exposed to passive cigarette smoke.

Preliminary blinded results from it’s Phase IIa trial with E1-I.N.T. showed 3 of the first 4 type I diabetes patients had a 35-75% reduction in daytime insulin usage following a 28 day treatment.

Studies in animals suggest that brown seaweed, also known as wakame — commonly used to flavor Asian soups and salads, contains a compound that promotes weight loss. The compound, called fucoxanthin, also has anti-diabetes effects.

Actos® (pioglitazone HCl), an oral antidiabetic medication, demonstrated significant cardiovascular benefits in reducing the risk of heart attack and/or stroke and acute coronary syndrome in patients with type 2 diabetes.